Overall market sentiment has been high on Radius Health Inc (RDUS) stock lately. RDUS receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
Radius Health Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on RDUS!
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With RDUS Stock Today?
Radius Health Inc (RDUS) stock is trading at $10.15 as of 12:06 PM on Tuesday, Aug 9, a loss of -$0.07, or -0.73% from the previous closing price of $10.22. The stock has traded between $10.09 and $10.18 so far today. Volume today is light. So far 423,301 shares have traded compared to average volume of 1,009,926 shares.
To see InvestorsObserver's Sentiment Score for Radius Health Inc click here.
More About Radius Health Inc
Radius Health Inc is an integrated biopharmaceutical company. It develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company's product, TYMLOS, is for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. The product pipeline of the company includes Abaloparatide-patch for the treatment of postmenopausal women with osteoporosis, Elacestrant, and RAD140.
Click Here to get the full Stock Report for Radius Health Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
